A detailed history of Zimmer Partners, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Zimmer Partners, LP holds 205,400 shares of MRK stock, worth $20.1 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
205,400
Previous 150,100 36.84%
Holding current value
$20.1 Million
Previous $18.6 Million 25.52%
% of portfolio
0.46%
Previous 0.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $6.15 Million - $7.13 Million
55,300 Added 36.84%
205,400 $23.3 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $20.1 Million - $21.6 Million
-162,175 Reduced 51.93%
150,100 $18.6 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $16.1 Million - $18.8 Million
142,275 Added 83.69%
312,275 $41.2 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $17 Million - $18.5 Million
170,000 New
170,000 $18.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Zimmer Partners, LP Portfolio

Follow Zimmer Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Zimmer Partners, LP with notifications on news.